Markets dipped Thursday as Coty issued a dismal forecast, Gilead faced headwinds with its new HIV drug, and investors turned cautious ahead of Fed Chair Powell’s Jackson Hole speech. Solid PMI data complicated the interest rate outlook, stalling hopes for imminent rate cuts.
Shares of beauty products company Coty (NYSE:COTY)
fell 19.4% in the morning session after the company reported a surprise loss for its second quarter as key profitability metrics declined.
Coty Inc (NYSE:COTY) shares are tumbling Thursday after the company posted a surprise loss for the fourth quarter. Multiple analysts also cut price targets on the stock following the print.
As the US market prepares to open on Thursday, let's get an early glimpse into the pre-market session and identify the stocks leading the pack in terms of gains and losses.
Beauty products company Coty (NYSE:COTY) reported Q2 CY2025 results exceeding the market’s revenue expectations, but sales fell by 8.1% year on year to $1.25 billion. Its non-GAAP loss of $0.05 per share was significantly below analysts’ consensus estimates.
Beauty products company Coty (NYSE:COTY) reported Q2 CY2025 results exceeding the market’s revenue expectations, but sales fell by 8.1% year on year to $1.25 billion. Its non-GAAP loss of $0.05 per share was significantly below analysts’ consensus estimates.
Shares of global beauty maker Coty are moving lower in extended trading Wednesday after the company reported mixed results for the fourth quarter of fiscal 2025.
Coty (COTY) Q4 revenue beat estimates but a surprise loss sent shares tumbling. The beauty giant faces near-term headwinds but forecasts a return to growth in H2 FY26.
